Christiansen L, Bygum A, Jensen A, Brandrup F, Thomsen K, Horder M, Petersen N E
Department of Clinical Biochemistry and Clinical Genetics, Odense University Hospital, Denmark.
Scand J Clin Lab Invest. 2000 Nov;60(7):611-5. doi: 10.1080/003655100448365.
Decreased uroporphyrinogen decarboxylase (UROD) activity is a characteristic feature of the most common of the porphyrias, porphyria cutanea tarda (PCT). A subgroup of the clinically overt PCT cases is associated with mutations in the gene encoding UROD and inherited as an autosomal-dominant trait. In this study, DNAs from 53 Danish PCT patients were subjected to genetic analysis for UROD mutations using denaturing gradient gel electrophoresis. Eleven genetic variations, seven of which are possible disease causing, were identified. All but one of these mutations were previously unknown, lending further support to the assumption that PCT is a heteroallelic disease. Only 11% of the examined patients were previously recognized as familial PCT cases. However, possible disease-related UROD mutations were identified in 24% of the examined patients, indicating that genetic analysis of PCT patients may improve differentiation between familial and sporadic PCT cases.
尿卟啉原脱羧酶(UROD)活性降低是最常见的卟啉病——迟发性皮肤卟啉病(PCT)的一个特征。临床上明显的PCT病例中有一个亚组与编码UROD的基因突变有关,并以常染色体显性性状遗传。在本研究中,对53名丹麦PCT患者的DNA进行变性梯度凝胶电泳,以分析UROD突变的基因。鉴定出11种基因变异,其中7种可能导致疾病。除一种突变外,所有这些突变以前均不为人知,这进一步支持了PCT是一种杂合等位基因疾病的假设。之前只有11%的受检患者被认定为家族性PCT病例。然而,在24%的受检患者中发现了可能与疾病相关的UROD突变,这表明对PCT患者进行基因分析可能有助于改善家族性和散发性PCT病例之间的区分。